Incontrast to MR-proANP, a high concentration of galectin-3 observed on admissionfound also to be a significant factor predicting late MACE in patients with AMI.Although no single universal cardiac biomarker appears to exist for predictingMACE in patients with acute myocardial infarction, galectin-3 seems to be aneffective predictor of both early and late MACE. The gene discussed is LGALS3; the disease is myocardial infarction.